quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:34:16·1d
SECFiling
Boston Scientific Corporation logo

Boston Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

BSX· Boston Scientific Corporation
Health Care
Original source

Companies

  • BSX
    Boston Scientific Corporation
    Health Care

Recent analyst ratings

  • Mar 30UpdateRaymond James$88.00
  • Oct 3UpdateErste Group-
  • Sep 8UpdateOppenheimer$125.00
  • Jun 16UpdateLeerink Partners$118.00
  • Apr 16UpdateNeedham$113.00
  • Jan 10UpdateDeutsche Bank$108.00

Related

  • PR1d
    Boston Scientific announces results for first quarter 2026
  • SEC22d
    SEC Form EFFECT filed by Boston Scientific Corporation
  • SEC22d
    SEC Form 424B3 filed by Boston Scientific Corporation
  • ANALYST24d
    Boston Scientific downgraded by Raymond James with a new price target
  • PR24d
    Boston Scientific announces conference call discussing first quarter 2026 results
  • SEC24d
    Amendment: SEC Form S-4/A filed by Boston Scientific Corporation
  • SEC24d
    Boston Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR26d
    CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022